Cart
sales@molnova.com
NNC 92-1687
CAS No. 22903-37-3
NNC 92-1687( —— )
Catalog No. M34348 CAS No. 22903-37-3
NNC 92-1687 is a selective glucagon receptor antagonist that can be used to study type 2 diabetes.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 550 | In Stock |
|
| 5MG | 834 | In Stock |
|
| 10MG | 1121 | In Stock |
|
| 25MG | 1501 | In Stock |
|
| 50MG | 1841 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameNNC 92-1687
-
NoteResearch use only, not for human use.
-
Brief DescriptionNNC 92-1687 is a selective glucagon receptor antagonist that can be used to study type 2 diabetes.
-
DescriptionNNC 92-1687 is a selective glucagon receptor antagonist that can be used to study type 2 diabetes.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetGlucagon Receptor
-
RecptorGlucagon Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number22903-37-3
-
Formula Weight300.33
-
Molecular FormulaC15H12N2O3S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESS(CC(=O)C1=CC(O)=C(O)C=C1)C=2NC=3C(N2)=CC=CC3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Semaglutide
Semaglutide has two amino acid substitutions compared to human GLP-1 (Aib8, Arg34) and is derivatized at lysine 26.
-
Lotiglipron
Lotiglipron (PF-07081532) is an orally active, potent GLP-1R agonist that reduces blood glucose and body weight, potentially aiding in the study of type 2 diabetes mellitus (T2DM) and obesity.
-
GLP-1R modulator C5
GLP-1R modulator C5 is a small molecule GLP-1R orthosteric modulator that enhances GLP-1 binding to GLP-1R via transmembrane sites and can be used in the study of type II diabetes.
